News Quantified

CTKB – cytek biosciences, inc. (US:NASDAQ)

Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.

11/20

05:50 am

ctkb

Low

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]

Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]

TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]

TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}